Results 61 to 70 of about 4,338 (156)

Dyskeratosis congenita induced cirrhosis for liver transplantation-perioperative management

open access: yesIndian Journal of Anaesthesia, 2015
Dyskeratosis congenita (DC) is an inherited disorder with progressive multisystem involvement. End stage liver disease (ESLD) in patients with DC is rare.
Anshuman Singh   +3 more
doaj   +1 more source

A case of dyskeratosis congenita with squamous cell carcinoma of the maxilla: A case report and review of the literature

open access: yesOral and Maxillofacial Surgery Cases, 2020
Dyskeratosis congenita (DC) is commonly diagnosed clinically with three classic findings of 1) oral leukoplakia, 2) nail dystrophy, and 3) abnormal skin pigmentation.
John M. Le, DDS   +2 more
doaj   +1 more source

Carrier screening in the reproductive setting—Are there medical implications for the heterozygote?—A guide for clinicians

open access: yesPregnancy, Volume 2, Issue 3, May 2026.
Abstract Carrier screening for genetic conditions performed preconception or during pregnancy allows identification of fetal risk for inherited autosomal recessive and X‐linked conditions. The goal is to identify at‐risk patients/couples and offer them reproductive options such as preimplantation genetic diagnosis, prenatal testing, or targeted newborn
Emily B. Rosenfeld   +5 more
wiley   +1 more source

Global consensus on the management of melanin hyperpigmentation disorders

open access: yesJournal of the European Academy of Dermatology and Venereology, Volume 40, Issue 5, Page 760-772, May 2026.
A global Delphi consensus of 10 dermatology experts established evidence‐based recommendations for melanin hyperpigmentation disorders, providing unified classification, photoprotection guidance and treatment algorithms. This framework harmonizes terminology and supports individualized management across diverse skin types and health systems.
Thierry Passeron   +9 more
wiley   +1 more source

p53 downregulates the Fanconi anaemia DNA repair pathway

open access: yesNature Communications, 2016
P53 is regarded as the guardian of the genome, however it is known that mice with increased p53 activity display characteristics of dyskeratosis congenita.
Sara Jaber   +4 more
doaj   +1 more source

Clonally Distinct FLT3‐TKD Mutations in Host and Donor‐Derived AML After Double Cord Blood Transplant: A Case Report

open access: yeseJHaem, Volume 7, Issue 2, April 2026.
ABSTRACT Donor‐derived leukemia (DDL) is a rare complication of hematopoietic cell transplantation with poorly understood mechanisms. We report a case of DDL arising 1 year after double cord blood transplant for AML. The secondary leukemia demonstrated a distinct immunophenotype, donor origin, and novel mutations (FLT3 D835E, NPM1, NRAS) absent in the ...
Rebecca B. Rojansky   +3 more
wiley   +1 more source

Dyskeratosis Congenita Associated Non-Specific Interstitial Pneumonia [PDF]

open access: yesJournal of Krishna Institute of Medical Sciences University, 2017
Dyskeratosis Congenita (DC) is a rare inherited disorder of ectodermal dysplasia. It consists of a classical mucocutaneous triad of abnormal skin pigmentation, nail dystrophy and leukoplakia. Pulmonary disease is seen in 10-15%.
Unnati D. Desai , Jyotsna M. Joshi
doaj  

Dyskeratosis Congenita: A Report of Two Cases

open access: yesCase Reports in Dentistry, 2013
Oral manifestations play an important role in the diagnosis of many systemic conditions. Dyskeratosis congenita (DC) is a rare genodermatosis which exhibits oral leukoplakia, nail dystrophy, and reticular skin pigmentations as its primary features.
Anila Karunakaran   +4 more
doaj   +1 more source

The WHO Classification of Genetic Tumour Syndromes: Considerations for histopathology

open access: yes
Histopathology, Volume 88, Issue 7, Page 1291-1294, June 2026.
Ian A Cree   +18 more
wiley   +1 more source

Dyskeratosis Congenita

open access: yes
Garofola C, Nassereddin A, Gross GP.
europepmc   +2 more sources

Home - About - Disclaimer - Privacy